Primary interatrial foramen

From WikiMD's WELLNESSPEDIA

Diagram of the human heart. The primary interatrial foramen is a structure in the embryonic heart.

The Primary Interatrial Foramen is a crucial structure in the embryonic heart that allows the flow of blood between the left and right atria before the formation of the foramen ovale.

Development[edit]

During the embryonic development of the heart, the primary interatrial foramen forms as a result of the degradation of the dorsal part of the septum primum. This degradation is necessary to maintain the connection between the left and right atria after the septum primum begins to close the interatrial septum.

Function[edit]

The primary function of the primary interatrial foramen is to allow the flow of oxygenated blood from the right atrium to the left atrium. This is crucial during fetal development as the lungs are not yet functional and the fetus relies on the mother's oxygen supply.

Closure[edit]

The primary interatrial foramen closes shortly after birth when the lungs become functional and the foramen ovale closes. This closure prevents the mixing of oxygenated and deoxygenated blood in the heart, allowing for efficient oxygen delivery to the body's tissues.

Clinical Significance[edit]

If the primary interatrial foramen fails to close after birth, it can result in a condition known as patent foramen ovale. This can lead to a number of health issues, including stroke and heart failure.

See Also[edit]

References[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.